Table 1.
Pathogen | Mediator | Mechanism of action | Refs. |
---|---|---|---|
Group A Streptococci | Sda1 | NET degradation | [8–10] |
Streptokinase | Fibrinolysis | [76, 77] | |
Streptococcus pneumoniae | Endonuclease | NET degradation | [11] |
Staphylococcus aureus | Endonucleases | NET degradation | [12, 13] |
Staphylocoagulase | NET degradation | [78, 79] | |
vWF-binding protein | Exploitation of coagulation | [78, 79] | |
CLFA and CLFB | Platelet aggregation | [74] | |
Pseudomonas aeruginosa | Sialic acid | Molecular mimicry | [14, 16] |
Aspergillus fumigatus, A. nidulans | RodA | Molecular mimicry | [7] |
Mycobacterium tuberculosis H37Rv | High lipid cell wall content | Molecular mimicry | [19, 23] |
Mycobacterium canetti | High lipid cell wall content | Molecular mimicry | [23] |
Mycobacterium bovis BCG | Mφ-ingested PMN CG and NE | Modulation of NETosis | [25, 26] |
Mycobacterium smegmatis | Microparticles and ectosomes | Modulation of NETosis | [27, 28] |
IFNγ and ESX-1 system | Modulation of NETosis | [29] | |
Leishmania amazonensis | Coinfection with FeLV | Modulation of NETosis | [84] |
Human immmunodeficiency virus | CD209 binding | Modulation of NETosis | [86, 87] |
NET neutrophil extracellular trap, vWF von Willebrand factor, CLFA clumping factor A, CLFB clumping factor B, RodA hydrophobin RodA protein, BCG bacillus Calmette-Guérin, Mφ macrophage, PMN polymorphonuclear neutrophil, CG cathepsin-G, NE neutrophil elastase, IFNγ interferon gamma, ESX-1 mycobacterial ESX-1 secretion system, FeLV feline leukemia virus